⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1445741 | 0.77 | — | — | |
| SCHEMBL19133532 | 0.77 | — | — | |
| SCHEMBL15742795 | 0.76 | NOTUM (0.41) | — | |
| SCHEMBL3030633 | 0.76 | HSD11B1 (0.34) | — | |
| SCHEMBL8682876 | 0.76 | NOTUM (0.32) | — | |
| SCHEMBL16793404 | 0.76 | — | — | |
| SCHEMBL15742745 | 0.76 | — | — | |
| SCHEMBL16793402 | 0.76 | — | — | |
| SCHEMBL15742625 | 0.76 | — | — | |
| SCHEMBL12817284 | 0.75 | NOTUM (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 366 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230092935-A1 | CERIUM (IV) COMPLEXES AND THEIR USE IN ORGANIC ELECTRONICS | Credoxys GmbH (DE) | 2023-03-23 | — | — | US | claimed |
| WO-2018154244-A1 | METHOD FOR THE SYNTHESIS OF PHEROMONES | DEMETA (FR) | 2018-08-30 | — | — | WO | claimed |
| US-20120220775-A1 | ENANTIOSELECTIVE PREPARATION OF QUINOLINE DERIVATIVES | LOHSE OLIVIER (FR) | 2012-08-30 | — | — | US | claimed |
| EP-2190466-A2 | TISSUE-NONSPECIFIC ALKALINE PHOSPHATASE (TNAP) ACTIVATORS AND USES THEREOF | Burnham Institute for Medical Research (US) | 2010-06-02 | — | — | EP | claimed |
| EP-1791820-B1 | ENANTIOSELECTIVE PREPARATION OF QUINOLINE DERIVATIVES | NOVARTIS AG (CH) | 2009-12-02 | — | — | EP | claimed |
| WO-2009042294-A2 | TISSUE-NONSPECIFIC ALKALINE PHOSPHATASE (TNAP) ACTIVATORS AND USES THEREOF | BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) | 2009-04-02 | — | — | WO | claimed |
| US-20090054653-A1 | ENANTIOSELEKTIVE PREPARATION OF QUINOLINE DERIVATIVE | LOHSE OLIVIER | 2009-02-26 | — | — | US | claimed |
| US-20090053192-A1 | TISSUE-NONSPECIFIC ALKALINE PHOSPHATASE (TNAP) ACTIVATORS AND USES THEREOF | BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) | 2009-02-26 | — | — | US | claimed |
| US-20080312462-A1 | Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives | SEDELMEIER GOTTFRIED | 2008-12-18 | — | — | US | claimed |
| US-20070155970-A1 | PROCESS FOR THE MANUFACTURE OF HMG-COA REDUCTASE INHIBITORY MEVALONIC ACID DERIVATIVES | SEDELMEIER GOTTFRIED | 2007-07-05 | — | — | US | claimed |
| EP-1791820-A2 | ENANTIOSELECTIVE PREPARATION OF QUINOLINE DERIVATIVES | Novartis AG (CH) | 2007-06-06 | — | — | EP | claimed |
| WO-2005123684-A2 | ENANTIOSELEKTIVE PREPARATION OF QUINOLINE DERIVATIVE | NOVARTIS AG (CH) | 2005-12-29 | — | — | WO | claimed |
| US-20050159480-A1 | Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives | NOVARTIS AG (CH) | 2005-07-21 | — | — | US | claimed |
| EP-1478640-A1 | PROCESS FOR THE MANUFACTURE OF HMG-COA REDUCTASE INHIBITORY MEVALONIC ACID DERIVATIVES | Novartis AG (CH) | 2004-11-24 | — | — | EP | claimed |
| WO-2003070717-A1 | PROCESS FOR THE MANUFACTURE OF HMG-COA REDUCTASE INHIBITORY MEVALONIC ACID DERIVATIVES | NOVARTIS AG (CH) | 2003-08-28 | — | — | WO | claimed |
| US-5399780-A | Method of producing triarylborane | TOSOH AKZO CORPORATION (JP) | 1995-03-21 | — | — | US | claimed |
| EP-4394981-A1 | NONAQUEOUS ELECTROLYTE AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-07-03 | — | — | EP | disclosed |
| EP-4006040-A1 | PYRROMETHENE-BORON COMPLEX, COLOR CONVERSION COMPOSITION, COLOR CONVERSION FILM, LIGHT SOURCE UNIT, DISPLAY, AND LIGHTING DEVICE | Toray Industries, Inc. (JP) | 2022-06-01 | — | — | EP | disclosed |
| EP-0498680-A1 | New beta-amino-alpha-hydroxycarboxylic acids and their use | Sankyo Company Limited (JP) | 1992-08-12 | — | — | EP | disclosed |
| EP-0437016-A2 | Lipid A analogues having immunoactivating and anti-tumour activity | Sankyo Company Limited (JP) | 1991-07-17 | — | — | EP | disclosed |